Health consequences of the Burden of atrial fibrillation The added information of measuring AF burden and measuring cardiac dimensions and function in an AF patient population where brain MRIs are available, could provide further evidence toward...

Clinical Studies - Apr 6, 2020 - Apr 6, 2024

Completed

Project leader: Ammann Peter
Members: Altmann David, Fink Karin

Nicht-interventionelle Studie zur Edoxaban-Therapie in der klinischen Routinepraxis bei Patienten mit nicht-valvulärem Vorhofflimmern (Non-interventional study on Edoxaban Treatment in routiNe clinical prActise for patients with non valvular Atrial F...

Clinical Studies - Dec 6, 2016 - Dec 15, 2021

Completed

Project leader: Ammann Peter
Members: Gemperle Michaela, Altmann David

To increase our knowledge on structural brain damage and its changes over time in patients with AF 2. To gain additional insights on the incidence and underlying mechanisms of cognitive decline in patients with AF 3. To improve long term risk pre...

Clinical Studies - Jun 12, 2014 - Jan 1, 2032

Ongoing

Project leader: Ammann Peter
Members: Altmann David, Gemperle Michaela, Kopp Sebastian, Fink Karin, Brenner Roman, Vetsch Susanne

Canakinumab for the prevention of recurrences after electrical cardioversion in patients with persistent atrial fibrillation (CONVERT-AF) trial Primary objective: To determine the effect of canakinumab on atrial fibrillation (AF) recurrences withi...

Clinical Studies - Jun 20, 2013 - Jun 20, 2017

Aborted

Project leader: Ammann Peter
Members: Altmann David, Gemperle Michaela

Eine prospektive Studie zur Prognostizierbarkeit der Therapie Qualität mit Priorität auf die schmerzfreie ATP Therapie Das Ziel dieser klinischen Studie ist es, die Effektivität und die Auftretungshäufigkeit der vom ICD-Gerät (Implantierbarer Kardio...

Clinical Studies - Jan 3, 2013 - Dec 31, 2015

Completed

Project leader: Ammann Peter
Members: Altmann David, Rohner Franziska, Gemperle Michaela, Schefer Mirjam